Silvers Jason's Form 4 filing
Generate Biomedicines, Inc. (GENB) · filed Mar 2, 2026
- Accession no.
- 0001193125-26-085898
- Filed
- Mar 2, 2026
- Trade date
- Feb 26-Mar 2, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market purchases total $32.0K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Silvers JasonCIK 0002109011 | Officer (President & CFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | Common Stock | PPurchaseAcquired | +500 | $16.00 | +$8,000 | 500 | Indirect | |
| Mar 2, 2026 | Common Stock | PPurchaseAcquired | +500 | $16.00 | +$8,000 | 500 | Indirect | |
| Mar 2, 2026 | Common Stock | PPurchaseAcquired | +1,000 | $16.00 | +$16,000 | 1,000 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | Common Stock | AGrant or awardAcquired | +295,608 | $0.00 | $0 | 295,608 | Direct | |
| Feb 26, 2026 | Common Stock | AGrant or awardAcquired | +274,493 | $0.00 | $0 | 274,493 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.